India: Drug price regulator going after major violators - (Business Line via NewsPoints Desk)

  • India's National Pharmaceutical Pricing Authority (NPPA) initiated 89 cases last year for overcharging on medicines, demanding more than 384 crore rupees in penalties, Business Line reported.
  • In the previous year, the regulator initiated 103 cases against drug companies, demanding 128 crore rupees as the overcharged amount.
  • NPPA chief CP Singh said the body is looking at big price violations, indicating that the department has prioritised some cases, while about 2000 are still pending.
  • Last year, NPPA demands for alleged overcharging included 14 crore rupees for USV’s Ecosprin and 26 crore rupees on Okasa’s Neutrolin syrup.
  • In the previous year, penalties included 104 crore rupees on Claris Life Sciences for its Eye V fluid; 7 crore rupees on Aventis Pharma; and 10 crore rupees on Cipla’s Burnheal cream.

To read more NewsPoints articles, click here.

Reference Articles